FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1504895308> ?p ?o ?g. }

• W1504895308 endingPage "652" @default.
• W1504895308 startingPage "647" @default.
• W1504895308 abstract "Dexmedetomidine (DEX) has been hypothesized to possess anti‑oxidative properties that may mitigate the damage caused by ischemia‑reperfusion (IR) injury. The aim of the present study was to examine the effects of DEX on intestinal contractile activity, inflammation and apoptosis following intestinal IR injury. Intestinal IR injury was induced in rats by complete occlusion of the superior mesenteric artery for 60 min, followed by a 60‑min reperfusion period. Rats received an intraperitoneal injection of 25 µg/kg DEX at 30 min prior to the mesenteric IR injury. Following reperfusion, segments of the terminal ileum were rapidly extracted and transferred into an isolated organ bath. The contractile responses to receptor‑mediated acetylcholine (Ach) and non‑receptor‑mediated potassium chloride (KCl) were subsequently examined. Nitric oxide (NO) levels were determined and the expression levels of tumor necrosis factor (TNF)‑α, interleukin (IL)‑6, Bax and Bcl‑2 were measured using an enzyme‑linked immunosorbent assay. The levels of telomerase and caspase‑3 were determined using reverse transcription‑quantitative polymerase chain reaction. The results indicated that DEX treatment produced a significant reduction in the IR‑induced contractile response to Ach and KCl in the intestinal tissue. Furthermore, DEX appeared to significantly ameliorate intestinal IR injury, in addition to reducing the production of NO. Similar reductions were observed in the intestinal expression levels of TNF‑α and IL‑6. In addition, DEX treatment resulted in a reduction in the expression levels of Bax in the intestinal tissues, while increasing those of Bcl‑2, in addition to significantly increasing the mRNA levels of telomerase and caspase‑3. Therefore, the present study indicated that NO, TNF‑α and IL‑6 may partially contribute to the pathogenesis of intestinal IR injury in addition to the increased expression levels of Bax, Bcl‑2, telomerase and caspase‑3. These findings suggest that DEX possesses beneficial anti‑apoptotic and anti‑inflammatory effects in intestinal tissue following bowel injury." @default.
• W1504895308 created "2016-06-24" @default.
• W1504895308 creator A5001468952 @default.
• W1504895308 creator A5037432321 @default.
• W1504895308 creator A5040170167 @default.
• W1504895308 creator A5049179021 @default.
• W1504895308 creator A5049367192 @default.
• W1504895308 creator A5077896863 @default.
• W1504895308 date "2015-06-10" @default.
• W1504895308 modified "2023-10-05" @default.
• W1504895308 title "Protective effects of dexmedetomidine on intestinal ischemia-reperfusion injury" @default.
• W1504895308 cites W2001090039 @default.
• W1504895308 cites W2011475822 @default.
• W1504895308 cites W2013691388 @default.
• W1504895308 cites W2021322675 @default.
• W1504895308 cites W2022094953 @default.
• W1504895308 cites W2023504951 @default.
• W1504895308 cites W2027581280 @default.
• W1504895308 cites W2028933526 @default.
• W1504895308 cites W2033013903 @default.
• W1504895308 cites W2033899624 @default.
• W1504895308 cites W2034101983 @default.
• W1504895308 cites W2050239692 @default.
• W1504895308 cites W2051006677 @default.
• W1504895308 cites W2057276722 @default.
• W1504895308 cites W2061864656 @default.
• W1504895308 cites W2064588700 @default.
• W1504895308 cites W2066387478 @default.
• W1504895308 cites W2075863025 @default.
• W1504895308 cites W2099197551 @default.
• W1504895308 cites W2110678628 @default.
• W1504895308 cites W2117219797 @default.
• W1504895308 cites W2118134478 @default.
• W1504895308 cites W2141343882 @default.
• W1504895308 cites W2168620078 @default.
• W1504895308 cites W2416696001 @default.
• W1504895308 doi "https://doi.org/10.3892/etm.2015.2561" @default.
• W1504895308 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4509460" @default.
• W1504895308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26622369" @default.
• W1504895308 hasPublicationYear "2015" @default.
• W1504895308 type Work @default.
• W1504895308 sameAs 1504895308 @default.
• W1504895308 citedByCount "30" @default.
• W1504895308 countsByYear W15048953082016 @default.
• W1504895308 countsByYear W15048953082017 @default.
• W1504895308 countsByYear W15048953082018 @default.
• W1504895308 countsByYear W15048953082019 @default.
• W1504895308 countsByYear W15048953082020 @default.
• W1504895308 countsByYear W15048953082021 @default.
• W1504895308 countsByYear W15048953082022 @default.
• W1504895308 countsByYear W15048953082023 @default.
• W1504895308 crossrefType "journal-article" @default.
• W1504895308 hasAuthorship W1504895308A5001468952 @default.
• W1504895308 hasAuthorship W1504895308A5037432321 @default.
• W1504895308 hasAuthorship W1504895308A5040170167 @default.
• W1504895308 hasAuthorship W1504895308A5049179021 @default.
• W1504895308 hasAuthorship W1504895308A5049367192 @default.
• W1504895308 hasAuthorship W1504895308A5077896863 @default.
• W1504895308 hasBestOaLocation W15048953081 @default.
• W1504895308 hasConcept C126322002 @default.
• W1504895308 hasConcept C134018914 @default.
• W1504895308 hasConcept C17991360 @default.
• W1504895308 hasConcept C185592680 @default.
• W1504895308 hasConcept C190283241 @default.
• W1504895308 hasConcept C2776814716 @default.
• W1504895308 hasConcept C2777226302 @default.
• W1504895308 hasConcept C2780114680 @default.
• W1504895308 hasConcept C2781046184 @default.
• W1504895308 hasConcept C2781302539 @default.
• W1504895308 hasConcept C519581460 @default.
• W1504895308 hasConcept C541997718 @default.
• W1504895308 hasConcept C55493867 @default.
• W1504895308 hasConcept C71924100 @default.
• W1504895308 hasConcept C98274493 @default.
• W1504895308 hasConceptScore W1504895308C126322002 @default.
• W1504895308 hasConceptScore W1504895308C134018914 @default.
• W1504895308 hasConceptScore W1504895308C17991360 @default.
• W1504895308 hasConceptScore W1504895308C185592680 @default.
• W1504895308 hasConceptScore W1504895308C190283241 @default.
• W1504895308 hasConceptScore W1504895308C2776814716 @default.
• W1504895308 hasConceptScore W1504895308C2777226302 @default.
• W1504895308 hasConceptScore W1504895308C2780114680 @default.
• W1504895308 hasConceptScore W1504895308C2781046184 @default.
• W1504895308 hasConceptScore W1504895308C2781302539 @default.
• W1504895308 hasConceptScore W1504895308C519581460 @default.
• W1504895308 hasConceptScore W1504895308C541997718 @default.
• W1504895308 hasConceptScore W1504895308C55493867 @default.
• W1504895308 hasConceptScore W1504895308C71924100 @default.
• W1504895308 hasConceptScore W1504895308C98274493 @default.
• W1504895308 hasIssue "2" @default.
• W1504895308 hasLocation W15048953081 @default.
• W1504895308 hasLocation W15048953082 @default.
• W1504895308 hasLocation W15048953083 @default.
• W1504895308 hasLocation W15048953084 @default.
• W1504895308 hasOpenAccess W1504895308 @default.
• W1504895308 hasPrimaryLocation W15048953081 @default.
• W1504895308 hasRelatedWork W1977918131 @default.
• W1504895308 hasRelatedWork W1990717759 @default.

• next